Anthropic has launched its own internal drug discovery programs, focusing on diseases that are considered unprofitable by big pharmaceutical companies. The company is utilizing its AI capabilities, including a tool called Claude Science, to support its drug discovery efforts. Claude Science is a platform for scientific research that is now available, although details about its specific applications and capabilities are not fully clear.